AZD 1222

DRUG2 trials

Sponsors

University Medicine Greifswald, Botswana Harvard AIDS Institute Partnership

Conditions

COVID-19SARS-CoV-2 Vaccination

Phase 3

Incidence of COVID-19 Following Vaccination in Botswana Against SARS CoV 2

CompletedNCT05715944

Botswana Harvard AIDS Institute PartnershipCOVID-19

Start: 2021-09-15End: 2022-12-30Updated: 2023-02-08

Unknown Phase

Adaptive Immune Response to COVID-19 Vaccination

University Medicine GreifswaldSARS-CoV-2 Vaccination

Start: 2021-01-06End: 2023-12-31Updated: 2023-10-03